PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Paulzen M. Int J Neuropsychopharmacol. Feb 2007; 10(1): 149-51 Pubmed [3000]
Paulzen M. Int J Neuropsychopharmacol. Mar 2008; 11(2): 289-91 Pubmed [2548]
Paulzen M. J Affect Disord. Nov 2017; 227: 506-511 Pubmed [4750]
Paulzen M. J Clin Psychopharmacol. Feb 2016; 36(1): 90-2 Pubmed [2445]
Paulzen M. J Psychopharmacol. Aug 2016; 30(8): 803-9 Pubmed [4850]
Paulzen M. Pharmacopsychiatry. Nov 2011; 44(7): 317-23 Pubmed [2524]
Paulzen M. Prog Neuropsychopharmacol Biol Psychiatry. Apr 2018 Pubmed [4948]
Pautola L. Duodecim. Jan 2012; 128(10): 1031-2 Pubmed [9989]
Pauwels O. Pharmacol Res. Apr 2002; 45(4): 291-8 Pubmed [5827]
Pavelic AR. Cells. Dec 2022; 12(1) Pubmed [13501]
Pawar PS. Am J Geriatr Pharmacother. Dec 2010; 8(6): 595-8 Pubmed [521]
Pawlowska M. Eur J Clin Pharmacol. Jun 2015; 71(6): 699-705 Pubmed [8046]
Pea F. Ann Pharmacother. Nov 2008; 42(11): 1711-6 Pubmed [5919]
Pea F. Antivir Ther. Jan 2008; 13(5): 739-42 Pubmed [7062]
Pea F. Clin Pharmacokinet. Jan 2001; 40(11): 833-68 Pubmed [7511]
Pea F. Transpl Infect Dis. Dec 2015; 17(6): 926-8 Pubmed [7017]
Peacock LE. Age Ageing. Jul 2011; 40(4): 528 Pubmed [3292]
Peano C. Ann Emerg Med. Nov 1997; 30(5): 704-8 Pubmed [2626]
Pearce RE. Drug Metab Dispos. Jun 2006; 34(6): 1035-40 Pubmed [4726]
Pearce RE. Drug Metab Dispos. Nov 2002; 30(11): 1170-9 Pubmed [74]
Pearce RE. Drug Metab Dispos. Sep 2013; 41(9): 1686-94 Pubmed, Volltext, DOI [5299]
Pecikoza U. Psychopharmacology (Berl). May 2020; 237(5): 1435-1446 Pubmed [11957]
Pecora Fulco P. Ann Pharmacother. Nov 2018; 52(11): 1165-1166 Pubmed [6669]
Pecora Fulco P. Ann Pharmacother. Sep 2003; 37(9): 1325-8 Pubmed [6709]
Pedersen JK. Ugeskr Laeger. Sep 2016; 178(39) Pubmed [5917]
Pedersen KE. Acta Med Scand. Jan 1985; 218(2): 229-32 Pubmed [382]
Pedersen OL. Eur J Clin Pharmacol. Jan 1982; 23(6): 513-21 Pubmed [3321]
Pedraz-Petrozzi B. Clin Case Rep. Mar 2023; 11(3): e7045 Pubmed [12980]
Pedroso JL. Neurologist. Mar 2011; 17(2): 89-90 Pubmed [10587]
Peet CF. Eur J Drug Metab Pharmacokinet. Oct 2005; 30(4): 275-86 Pubmed [7985]
Peet M, Middlemiss DN, Yates RA. Pharmacocinetic interaction between propanolol and chlorpromazine in schizophrenic patients. Lancet (1980) ii, 978 [923]
Peet M, Middlemiss DN, Yates RA. Propanolol in schizophrenia II. Clinical and biochemical aspects of combining propanolol with chlorpromazine. Br J Psychiatry (1081) 138, 112-7 [924]
Peet M. Drug Saf. Feb 1995; 12(2): 146-53 Pubmed [8962]
Peeters M. Ann Pharmacother. Jun 2008; 42(6): 757-65 Pubmed [8455]
Peihua L. Open Med (Wars). Jul 2018; 13: 270-277 Pubmed, Volltext, DOI [10441]
Peitz GJ. South Med J. Apr 2009; 102(4): 411-2 Pubmed [9537]
Pejčić AV. Int J Psychiatry Clin Pract. Mar 2022; 26(1): 29-42 Pubmed [12398]
Pelet A. Am J Drug Alcohol Abuse. Jul 2011; 37(4): 264-8 Pubmed [6307]
Pelkonen O. Arch Toxicol. Oct 2008; 82(10): 667-715 Pubmed [3716]
Pelkonen O. Toxicology. Apr 2000; 144(1-3): 139-47 Pubmed [4422]
Pellene A. Clin Neuropharmacol. Nov 2015; 38(6): 252-4 Pubmed [10394]
Pelton GH. Contemp Clin Trials. Mar 2014; 37(2): 200-8 Pubmed [13119]
Pelton GH. Int J Geriatr Psychiatry. Jun 2016; 31(6): 648-55 Pubmed [9951]
Peltoniemi MA. Clin Pharmacokinet. Sep 2016; 55(9): 1059-77 Pubmed [5159]
Peltoniemi MA. Eur J Clin Pharmacol. Jun 2012; 68(6): 979-86 Pubmed [3709]
Peña E. Brain Sci. Feb 2021; 11(2) Pubmed [12227]
Pence BW. AIDS Behav. Jun 2014; 18(6): 1142-51 Pubmed, Volltext, Springer [3808]
Peng B. Clin Pharmacokinet. Jan 2005; 44(9): 879-94 Pubmed [4899]
Pennachio D.L. Patient Care. Oct 2000; 34(19) Pubmed [11617]
Penning-van Beest FJ. J Thromb Haemost. Feb 2008; 6(2): 284-90 Pubmed [9384]
Penninga EI. Basic Clin Pharmacol Toxicol. Jan 2016; 118(1): 37-44 Pubmed [5097]
Pentikäinen PJ et al. Acta Pharmacol Toxicol (1986) 59 (Suppl 5), 91 [2140]
Penttilå O. Br Med J. Jun 1974; 2(5917): 470-2 Pubmed, Volltext [5626]
Penzak et al. J Clin Psychopharmacol 2002;2(4):366-370 [3009]
Penzak SR. Am J Cardiovasc Drugs. Jan 2002; 2(2): 91-106 Pubmed [6901]
Penzak SR. J Acquir Immune Defic Syndr. Dec 2005; 40(5): 573-80 Pubmed [6476]
Penzak SR. Ther Drug Monit. Jun 2004; 26(3): 322-30 Pubmed [6416]
Penzner JB. J Child Adolesc Psychopharmacol. Oct 2009; 19(5): 563-73 Pubmed, Volltext, DOI [3280]
Perazella MA. Am J Med Sci. Jun 2003; 325(6): 349-62 Pubmed [5695]
Perdix (Moexipril), Schwarz Pharma Ltd. Summary of product characteristics, March 2000 [1734]
Pereira BB. J Toxicol Environ Health B Crit Rev. Apr 2020; : 1-5 Pubmed [8904]
Pereira MA. Rev Bras Anestesiol. Jan 1972; 22(1): 10-9 Pubmed [10000]
Peremans K. Nucl Med Commun. Aug 2008; 29(8): 724-9 Pubmed [4789]
Perez Jimenez TE. Drug Metab Dispos. Oct 2016 Pubmed, Volltext, DOI [4332]
Perez Ruixo JJ. J Clin Pharmacol. Mar 2015; 55 Suppl 3: S85-92 Pubmed [4017]
Perez-Lloret S. CNS Drugs. Aug 2016; 30(8): 703-17 Pubmed [10439]
Pérez-Torre P. Neurologia (Engl Ed). Sep 2021 Pubmed [12181]
Pergolizzi J. Pain Pract. Jul 2008; 8(4): 287-313 Pubmed [8991]
Pericàs JM. Clin Microbiol Infect. Jun 2018; 24(6): 673-676 Pubmed [8121]
Periclou A. Eur J Drug Metab Pharmacokinet. Jan 2021; 46(1): 53-69 Pubmed [11179]
Periclou A. J Clin Pharmacol. Apr 2010; 50(4): 422-33 Pubmed [3556]
Peritogiannis et al. (2007) J Clin Psychopharmacol 27(2):235-238 [2964]
Peritogiannis et al. Schizophr Res. 2005 Nov 15;79(2-3):345-6 [1471]
Peritogiannis V. Gen Hosp Psychiatry. May 2007; 29(3): 281-2 Pubmed [6237]
Peritogiannis V. Schizophr Res. Nov 2005; 79(2-3): 345-6 Pubmed [8963]
Perlemuter G. CNS Drugs. Sep 2016; 30(9): 877-88 Pubmed [4990]
Perlman BB. Lancet. Feb 1990; 335(8686): 416 Pubmed [1721]
Perloff ES. Drug Metab Dispos. Jun 2005; 33(6): 764-70 Pubmed [6301]
Perloff MD. J Pharm Sci. Nov 2001; 90(11): 1829-37 Pubmed [7974]
Perloff MD. Xenobiotica. Feb 2004; 34(2): 133-50 Pubmed [9705]
Perry CM. Drugs. Jul 1997; 54(1): 81-7; discussion 88 Pubmed [11950]
Perry LA. Cochrane Database Syst Rev. May 2018; 5: CD011943 Pubmed, Volltext, DOI [9871]
Perry ME. Int J STD AIDS. Aug 2013; 24(8): 639-42 Pubmed [7041]
Perry NK. Postgrad Med J. Apr 2000; 76(894): 254-6 Pubmed, Volltext, DOI [3270]
Perry PJ. J Clin Psychopharmacol. Feb 1993; 13(1): 46-51 Pubmed [1552]
Perse TL. Am J Psychiatry. Dec 1987; 144(12): 1543-8 Pubmed [12920]
Person, Siwers. Swed Dent J (1975) 68, 9-18 [1946]
Persson CG. Life Sci. Mar 1986; 38(12): 1057-72 Pubmed [6938]
Persson MP. Clin Pharmacol Ther. Mar 1988; 43(3): 324-31 Pubmed [1852]
Pertz HH. Planta Med. Jul 2011; 77(10): 973-8 Pubmed [12324]
Perucca Br J Clin Pharmacol 2005; 61:246-255 [2063]
Perucca E. Br J Clin Pharmacol. Aug 1977; 4(4): 485-6 Pubmed, Volltext [1596]
Perucca E. Br J Clin Pharmacol. Mar 2006; 61(3): 246-55 Pubmed, Volltext, DOI [427]
Perucca E. Clin Pharmacokinet. Jan 1982; 7(1): 57-84 Pubmed [9296]
Perucca E. Clin Pharmacokinet. Jul 1996; 31(1): 29-46 Pubmed [9350]
Perucca E. Clin Pharmacol Ther. Nov 1994; 56(5): 471-6 Pubmed [1473]
Perucca E. Epilepsia. Jan 1999; 40 Suppl 9: S7-13 Pubmed [9416]
Perucca E. Epilepsia. Jul 2008; 49(7): 1123-41 Pubmed [470]
Perucca E. Epilepsy Res. Feb 2003; 53(1-2): 47-56 Pubmed [9331]
Perucca Emilio, Johannessen Svein I, Treatment of Epilepsy: Focus on Levetiracetam. The ideal pharmacokinetic properties of an antiepileptic drug: how close does Ievetiracetam come? Epileptic Disord 2003; 5 (Supp/ 7): S17-S26 [2562]